Navigation Links
Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
Date:11/26/2007

BERKELEY HEIGHTS, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a company overview and update of corporate activities at the Lazard Capital Markets 4th Annual Healthcare Conference. Genta's presentation is scheduled for Wednesday, November 28th at 8:00 am EST at the New York Palace Hotel, New York, NY.

The presentation will be webcast and accessible at the Investor Relations section of the Company's website at: http://www.genta.com/investorrelation/events.html. The presentation will be archived for 30 days.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients for a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, which is currently undergoing initial clinical trials as a potential treatment for diseases associated with accelerated bo
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
6. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
7. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
8. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
9. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
10. Avicena Group to Present at Noble Financial Conference
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled ... 2pm EST (11am PST), “Natural Language Processing: Converting Raw ... technology can turn raw, heterogeneous data into actionable knowledge ... online webinar will last approximately one hour. , Synopsis: ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... ... , AMSTERDAM, December 8 , ... , Elsevier, a world-leading publisher of scientific, technical ... new SciVal Spotlight tool. The institutions, including,National Chiao Tung University (Taiwan), St. ...
... , ST. JOSEPH, Mich., Dec. 8 ... today that Millipore Corporation has sponsored academic groups from University ... collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner ... pathways and their application in analysis of experimental data as ...
... , , ANNAPOLIS, Md., Dec. ... a biodefense company specializing in the development and commercialization ... today that the Department of Health and Human Services ... request for proposal (RFP) for Recombinant Protective Antigen ...
Cached Biology Technology:SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 2SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 3Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 2Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4
(Date:4/24/2014)... A common plant puts out a welcome mat to bacteria ... mix. , The study published this week in the ... targets during the battle between microbe and host that researchers ... the humble and oft-studied plant Arabidopsis puts out ... It,s as if a hostile army were unknowingly passing by ...
(Date:4/23/2014)... and German . ... the difference between sexes depends on one single element of the ... the two sexual chromosomes are X and Y, whereas women have ... the morphological and physiological differences between males and females. , But ... ago, the X and Y were identical, until the Y started ...
(Date:4/23/2014)... Scarborough research shows that male black widow spiders prefer ... rare example of mate preference by male spiders. ... MacLeod and Maydianne Andrade, a professor in UTSC,s Department ... and the wild that males overwhelmingly chose to mate ... widows can tell whether a potential mate is well-fed ...
Breaking Biology News(10 mins):How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Male or female? 2Male or female? 3Picky male black widow spiders prefer well-fed virgins 2
... growth hormone (GH) by healthy elderly people found that the ... but not in body weight or other clinically important outcomes. ... of unhealthy side effects such as soft tissue swelling, joint ... They were also somewhat more likely to develop diabetes. ...
... evidence of the Earth's earliest forest trees, dating back 385 ... after a flash flood in Gilboa, upstate New York, more ... what the entire trees looked like. , Two years ... had fallen sideways, with their trunk, branches, twigs and crown ...
... method of mass-producing disease-fighting antibodies entirely within bacteria has ... of Texas at Austin. , The group led ... to improve upon processes used previously to identify new ... and labor-intensive processes to develop antibodies for treating rheumatoid ...
Cached Biology News:Growth hormone is not the anti-aging bullet for healthy adults 2Growth hormone is not the anti-aging bullet for healthy adults 3Cheaper, better disease treatments expected from faster approach to developing antibodies 2
... concentrator for efficient drying of small volumes ... system combines the SpeedVac™ Concentrator and chemically ... pump and rotor control, and dual timers ... time), makes the DNA120 indispensable in the ...
... Standard MB (For small quantities of solvents ... of vacuum concentrator/centrifugal evaporator systems respond to ... for rapid and safe concentration of heat-labile ... with pumps, different of cold traps and ...
... Jouan RC10 series of vacuum concentrators/centrifugal evaporators ... features allied to rapid and safe concentration ... be combined with oil-free or high vacuum ... a wide selection of rotors (eliminating sample ...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Biology Products: